Indicators
FDA Approved Drugs: Changes to Approved Drugs
Factors Affecting Activity Coefficient
Survey Safety
Recombinant DNA
Dysrhythmias VII: Nursing Management of Dysrhythmias
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Feb 7, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
E J Neufeld1, C Négrier2, S Benchikh El Fegoun3
1St. Jude Children's Research Hospital, Memphis, TN, USA.
No abstract available in PubMed .